Market Research Logo

BioLingus AG - Product Pipeline Review - 2016

BioLingus AG - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘BioLingus AG - Product Pipeline Review - 2016’, provides an overview of the BioLingus AG’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by BioLingus AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of BioLingus AG
  • The report provides overview of BioLingus AG including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses BioLingus AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features BioLingus AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate BioLingus AG’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for BioLingus AG
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding BioLingus AG’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
BioLingus AG Snapshot
BioLingus AG Overview
Key Facts
BioLingus AG - Research and Development Overview
Key Therapeutic Areas
BioLingus AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
BioLingus AG - Pipeline Products Glance
BioLingus AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
BioLingus AG - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
BioLingus AG - Drug Profiles
aldesleukin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy to Target Survivin for Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
exenatide biobetter - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
interferon alfa biobetter - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
interferon gamma - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
interleukin 2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Inhibit IL-23 for Crohn's Disease and Psoriasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptide to Agonize GLP-1 for Type 2 Diabetes - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptide to Inhibit PCSK9 for Hypercholesterolemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptide to Inhibit TNF-Alpha for Rheumatoid Arthritis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BioLingus AG - Pipeline Analysis
BioLingus AG - Pipeline Products by Target
BioLingus AG - Pipeline Products by Route of Administration
BioLingus AG - Pipeline Products by Molecule Type
BioLingus AG - Pipeline Products by Mechanism of Action
BioLingus AG - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
BioLingus AG, Key Facts
BioLingus AG - Pipeline by Indication, 2016
BioLingus AG - Pipeline by Stage of Development, 2016
BioLingus AG - Monotherapy Products in Pipeline, 2016
BioLingus AG - Preclinical, 2016
BioLingus AG - Discovery, 2016
BioLingus AG - Unknown, 2016
BioLingus AG - Pipeline by Target, 2016
BioLingus AG - Pipeline by Route of Administration, 2016
BioLingus AG - Pipeline by Molecule Type, 2016
BioLingus AG - Pipeline Products by Mechanism of Action, 2016
List of Figures
BioLingus AG - Pipeline by Top 10 Indication, 2016
BioLingus AG - Pipeline by Stage of Development, 2016
BioLingus AG - Monotherapy Products in Pipeline, 2016
BioLingus AG - Pipeline Target, 2016
BioLingus AG - Pipeline by Route of Administration, 2016
BioLingus AG - Pipeline by Molecule Type, 2016
BioLingus AG - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report